CRT 2017 : Japan FDA - Using Real-World Evidence to Support Marketing, Post-Marketing Safety Measures and Regulatory Decisions

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

Japan FDA - Using Real-World Evidence to Support Marketing, Post-Marketing Safety Measures and Regulatory Decisions

Featuring

  • Mitchell Krucoff
  • Hiroyoshi Yokoi
  • Pablo Morales
  • Jenny Andersen
  • Akihide Konishi

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Methods to Gather and Analyze RWE – US Academia - Mitchell Krucoff
Current Methodology and Future Horizons – Japanese Academia - Hiroyoshi Yokoi
Regulatory Perspectives on RWE – US Regulatory View - Pablo Morales
Issues and Current Experience Using RWE to Support Regulatory Applications – US Industry - Jenny Andersen
Using Post-Marketing Surveillance for Safety Measure – Japanese Regulatory View - Akihide Konishi

Target Audience

Learning Objectives

Related Moments

CRT 2017 : CARDIOVASCULAR INNOVATIONS - The Best Innovation for CRT 2016
Generic
Contemporary Antiplatelet Strategies In The Treatment Of STEMI Using Primary Percutaneous Coronary Intervention
Journal
Article on Contemporary Antiplatelet Strategies In The Treatment Of STEMI Using Primary Percutaneous Coronary Intervention
CRT 2016 Coronary - CTO Academy - Module IV: Live Case
Live Case
CTO Academy - Module IV: Live Case at CRT 2016
Loading Simple Education